Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liao-Shi-Hua-Feng-Dan registry for post-stroke limb symptoms
ChiCTR2200065554Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Dec 2021
- Countries
- 1
01
Overview
Phase 4, open-label trial of Liao-Shi-Hua-Feng-Dan in stroke, ischemic stroke, intracerebral hemorrhage (ICH) and 2 more (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: Visual Analogue Scale, Fugl-Meyer sensory function assessment (limbs) and 1 more. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
Liao-Shi-Hua-Feng-Dan
03
Conditions
strokeischemic strokeintracerebral hemorrhage (ICH)Post-stroke painMuscle spasm
Beyond the preview
Go deeper on ChiCTR2200065554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065554.